Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
2(50.0%)
N/A
2(50.0%)
4Total
Phase 1(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06756711Not ApplicableEnrolling By Invitation

Combination of Supplements for Treating Autistic Spectrum Disorder

Role: lead

NCT04007224Phase 1Completed

Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder

Role: lead

NCT03535974Not ApplicableCompleted

Efficacy of a Spirulina Supplement for Amelioration of Benign ThYroid Nodules

Role: lead

NCT03543917Phase 1Completed

Post-Stroke Improvement of Motor Function

Role: lead

All 4 trials loaded